These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12582473)

  • 1. Medical backgrounder: psoriasis.
    Travis L; Weinberg JM
    Drugs Today (Barc); 2002 Dec; 38(12):847-65. PubMed ID: 12582473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current consensus and update on psoriasis therapy: a perspective from the U.S.
    Koo JY
    J Dermatol; 1999 Nov; 26(11):723-33. PubMed ID: 10635614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis: current perspectives with an emphasis on treatment.
    Linden KG; Weinstein GD
    Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice of phototherapy in the treatment of moderate-to-severe psoriasis.
    Nguyen T; Gattu S; Pugashetti R; Koo J
    Curr Probl Dermatol; 2009; 38():59-78. PubMed ID: 19710550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of treatment modalities for psoriasis.
    Tristani-Firouzi P; Krueger GG
    Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
    Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis.
    Grundmann-Kollmann M; Ludwig R; Zollner TM; Ochsendorf F; Thaci D; Boehncke WH; Krutmann J; Kaufmann R; Podda M
    J Am Acad Dermatol; 2004 May; 50(5):734-9. PubMed ID: 15097957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psoriasis--clinical picture and current therapy].
    Shakery K; Reich K
    Med Monatsschr Pharm; 2009 Sep; 32(9):335-44; quiz 345-6. PubMed ID: 19795696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
    Feldman SR; Garton R; Averett W; Balkrishnan R; Vallee J
    Expert Opin Pharmacother; 2003 Sep; 4(9):1525-33. PubMed ID: 12943482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis.
    Burfield L; Burden AD
    J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategies: rotational therapy and combinations.
    van de Kerkhof PC
    Clin Exp Dermatol; 2001 Jun; 26(4):356-61. PubMed ID: 11422189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation.
    de Rie MA; Out TA; Bos JD
    Dermatology; 1998; 196(4):412-7. PubMed ID: 9669117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern concepts of the diagnosis and treatment of psoriasis.
    Edlich RF; Fisher AL; Chase ME; Brock CM; Gubler KD; Long WB
    J Environ Pathol Toxicol Oncol; 2009; 28(3):235-40. PubMed ID: 19888911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
    Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
    Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraviolet B Phototherapy for Psoriasis: Review of Practical Guidelines.
    Mehta D; Lim HW
    Am J Clin Dermatol; 2016 Apr; 17(2):125-33. PubMed ID: 26872953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for psoriasis and the risk of malignancy.
    Patel RV; Clark LN; Lebwohl M; Weinberg JM
    J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
    Coimbra S; Oliveira H; Belo L; Figueiredo A; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2013 Feb; 14(1):49-53. PubMed ID: 23329079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.
    Yosipovitch G; Tang MB
    Drugs Aging; 2002; 19(11):847-63. PubMed ID: 12428994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.